comparemela.com
Home
Live Updates
Targeting CD38/CD3 in the immunotherapy of Multiple Myeloma : comparemela.com
Targeting CD38/CD3 in the immunotherapy of Multiple Myeloma
Multiple myeloma is a common hematological malignancy that has its origins in plasma cells. Despite treatment becoming more sophisticated, there is still currently no cure. However, immunotherapy targeting CD38/CD3 is proving to be very promising.
Related Keywords
,
Research Phase ,
Sponsored Content ,
Heterodimer Protein ,
His Tag Free ,
Tag Free ,
Flag Tag ,
His Tag ,
Mouse Igg ,
Llama Igg ,
Labeled Human ,
Human Igg ,
Myeloma Cells ,
Its Role ,
Bone Marrow Microenvironment ,
Therapeutic Agents ,
Content Policy ,
News Medical Net ,
Cd38 ,
Immunotherapy ,
Multiple Myeloma ,
ஆராய்ச்சி கட்டம் ,
ஆதரவளிக்கப்பட்ட உள்ளடக்கம் ,
அவரது குறிச்சொல் ,
சுட்டி இக் ,
மனிதன் இக் ,
அதன் பங்கு ,
உள்ளடக்கம் பாலிஸீ ,
செய்தி மருத்துவ நிகர ,
comparemela.com © 2020. All Rights Reserved.